SCHEMBL2365735

SCHEMBL2365735

COC(=O)c1n[nH]c(=O)c(C)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.46
KDM4E B2RXH2 1/20 0.41
STAT3 P40763 1/20 0.41
HIF1A Q16665 1/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HCAR2 Q8TDS4 1/20 0.41
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.38
MAPK1 P28482 2/20 0.36
ALPL P05186 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 1/20 0.35
CYP1A2 P05177 1/20 0.35
HSD17B10 Q99714 2/20 0.35
F2 P00734 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.34
RNASEH1 O60930 1/20 0.34
PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17766421 0.80 HCAR2 (0.63) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL24424586 0.75 KDM4C (0.49) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL22424292 0.75 KDM4C (0.49) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL16453474 0.72 KDM4C (0.53) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL9213204 0.71 KDM4C (0.56) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL17224868 0.70 KDM4C (0.44) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL31459515 0.69 KDM4C (0.50) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL11089588 0.69 KDM4C (0.50) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL11169705 0.69 KMT2A (0.50) KDM4ESTAT3HIF1AALDH1A1L3MBTL1
SCHEMBL11160240 0.69 KMT2A (0.50) KDM4ESTAT3HIF1AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364973-A1 Heterocyclic inhibitors of MEK and Methods of use thereof Array Biopharma, Inc. (US) 2011-09-14 EP disclosed